摘要:
The invention provides polymorphs of Saxagliptin hydrochloride, processes for preparing polymorphs of Saxagliptin hydrocliloride, and pharmaceutical compositions of polymorphs of Saxagliptin hydrochloride.
摘要:
The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium.
摘要:
The present invention describes a novel baculovirus protein expression system in insect cells, where the expression of recombinant protein(s) is inducible. By the inducible expression systems of the invention, expression of the recombinant protein of interest can be repressed d u ring virus amplification, and thereafter activated in the presence or absence, respectively, of an inducing molecule or by a change in environmental conditions. The novel expression system does not produce significant levels of recombinant protein by baculovirus-infected cells during virus amplification prior to induction, thereby reducing selection pressure on the expression cassette for the recombinant protein. When induction is initiated, an increased yield of recombinant protein is thus produced relative to presently available, non-inducible baculovirus expression methods. Further, it is demonstrated herein that the yield of protein expression derived from the described methodology further increases relative to non-inducible systems as the scale of protein expression increases.
摘要:
A process for making a block copolymer compatibilizer comprises reacting an acrylic and/or vinyl monomer that has functional groups with one or more vinyl monomers in the presence of a free radical initiator and a stable free radical to form a reaction product that includes residual unreacted acrylic and/or vinyl monomer, and reacting one or more vinyl monomers with the reaction product to form a second block that incorporates the residual unreacted acrylic monomer. The block copolymer is used to compatibilize a clay nanocomposite material with a thermoplastic or thermoset resin. The block copolymer can be used with existing, commercially-available clays, or the block copolymer can be formed with a polar block that is miscible in a polar dispersion medium for use as a intercalate in producing a clay nanocomposite material.
摘要:
Novel solution complexes of zoledronic acid are described which give rise to improved properties of zoledronic acid. The invention includes aqueous solution and molecular complexes of zoledronic acid with and optical isomers of asparagine, histidine, arginine and proline as well as pharmaceutical complexes containing them and methods of treatment using them.
摘要:
The invention relates to a process for producing pharmaceutically acceptable salts of fingolimod (I), comprising the step of reacting N-[1,1-bis hydroxymethyl-3-(4-octyl phenyl)-propyl]-acylamide (II) with an acidic compound. Furthermore, the invention provides different pharmaceutically acceptable salts of fingolimod and a polymorphic form of fingolimod hydrochloride.
摘要:
The present invention provides crystalline forms of Fluticasone furoate, characterized by the data disclosed in the specification; pharmaceutical compositions comprising any one or combination of the crystalline forms of Fluticasone furoate and at least one pharmaceutically acceptable excipient; and the use of the crystalline forms of Fluticasone furoate in the preparation of pharmaceutical formulations.